| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A survey of yeast genomic assays for drug and target discovery
|
Smith, Andrew M.
|
|
2010
|
127 |
2 |
p. 156-164
9 p.
|
article
|
| 2 |
Cardiovascular risk factors regulate the expression of vascular endothelin receptors
|
Xu, Cang-Bao
|
|
2010
|
127 |
2 |
p. 148-155
8 p.
|
article
|
| 3 |
Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?
|
Geisler, Tobias
|
|
2010
|
127 |
2 |
p. 95-107
13 p.
|
article
|
| 4 |
ORAI-mediated calcium entry: Mechanism and roles, diseases and pharmacology
|
Roberts-Thomson, Sarah J.
|
|
2010
|
127 |
2 |
p. 121-130
10 p.
|
article
|
| 5 |
Recent therapeutic approaches to platelet activation in coronary artery disease
|
Tousoulis, Dimitris
|
|
2010
|
127 |
2 |
p. 108-120
13 p.
|
article
|
| 6 |
The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations
|
Tallarida, Ronald J.
|
|
2010
|
127 |
2 |
p. 165-174
10 p.
|
article
|
| 7 |
Therapeutic advances in myocardial microvascular resistance: Unravelling the enigma
|
Patel, Billal
|
|
2010
|
127 |
2 |
p. 131-147
17 p.
|
article
|
| 8 |
Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists
|
Dufton, Neil
|
|
2010
|
127 |
2 |
p. 175-188
14 p.
|
article
|
Journal description